Literature DB >> 21052851

Colorectal cancer: no longer the issue in familial adenomatous polyposis?

Daniel C Gibbons1, Ashish Sinha, Robin K S Phillips, Susan K Clark.   

Abstract

Familial adenomatous polyposis (FAP) is a dominantly inherited colorectal cancer (CRC) syndrome with an untreated lifetime prevalence of CRC close to 100% and extracolonic manifestations (ECM) of increasing clinical significance. This study examined the effect of systematic callup and prophylactic colectomy on FAP survival. Patients diagnosed, treated and followed-up at our institution were analysed. 'Callups' were those identified via the callup system; 'probands' were those identified by other means. Proportions were analysed by Chi-squared or Fischer's exact test. Mortality rates were indirectly standardised to the UK population. Survival curves from birth were estimated by Kaplan-Meier. A total of 439 patients (293 callups, 146 probands) were analysed. Crude mortality rates (CMRs) of callups and probands were 4.85 per 1,000 person years (PY) and 9.71 per 1,000 PY, respectively-a rate ratio of 0.50 (95% CI 0.34-0.72, P = 0.0001). The standardised mortality ratio (SMR) of callups was non-significantly lower than probands (4.12 vs. 4.70). Callups experienced non-significantly lower age-band specific SMR up to 45 years. More probands died of CRC (42.4 vs. 22.5%, P = 0.025), whereas more callups died of ECM (30.6 vs. 13.4%, P = 0.027). Median survival was 64 years for callups and 60 years for probands; survival curves did not differ significantly (P = 0.253). The crude mortality rate of callups is approximately half that of probands. As fewer callups die of CRC, a greater proportion die of ECMs. Callups experienced non-significantly reduced mortality up to 45 years. Whilst the FAP callup system reduces CRC risk, mortality attributable to ECMs needs to be addressed.

Entities:  

Mesh:

Year:  2011        PMID: 21052851     DOI: 10.1007/s10689-010-9394-x

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  11 in total

Review 1.  Familial adenomatous polyposis.

Authors:  Marcia Cruz-Correa; Francis M Giardiello
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

2.  Changing causes of mortality in patients with familial adenomatous polyposis.

Authors:  L A Belchetz; T Berk; B V Bapat; Z Cohen; S Gallinger
Journal:  Dis Colon Rectum       Date:  1996-04       Impact factor: 4.585

3.  Impact of screening examinations on survival in familial adenomatous polyposis.

Authors:  I Heiskanen; T Luostarinen; H J Järvinen
Journal:  Scand J Gastroenterol       Date:  2000-12       Impact factor: 2.423

4.  Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate.

Authors:  M L Bisgaard; K Fenger; S Bülow; E Niebuhr; J Mohr
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

5.  Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis.

Authors:  L Bertario; A Russo; P Sala; L Varesco; M Giarola; P Mondini; M Pierotti; P Spinelli; P Radice
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

Review 6.  Attenuated familial adenomatous polyposis (AFAP). A review of the literature.

Authors:  Anne Lyster Knudsen; Marie Luise Bisgaard; Steffen Bülow
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

7.  Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.

Authors:  S Bülow; C Bülow; T F Nielsen; L Karlsen; F Moesgaard
Journal:  Scand J Gastroenterol       Date:  1995-10       Impact factor: 2.423

8.  Colorectal polyp counts and cancer risk in familial adenomatous polyposis.

Authors:  H S Debinski; S Love; A D Spigelman; R K Phillips
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

9.  Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis.

Authors:  Stefan Aretz; Siegfried Uhlhaas; Reiner Caspari; Elisabeth Mangold; Constanze Pagenstecher; Peter Propping; Waltraut Friedl
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

10.  Guidelines for the clinical management of familial adenomatous polyposis (FAP).

Authors:  H F A Vasen; G Möslein; A Alonso; S Aretz; I Bernstein; L Bertario; I Blanco; S Bülow; J Burn; G Capella; C Colas; C Engel; I Frayling; W Friedl; F J Hes; S Hodgson; H Järvinen; J-P Mecklin; P Møller; T Myrhøi; F M Nagengast; Y Parc; R Phillips; S K Clark; M Ponz de Leon; L Renkonen-Sinisalo; J R Sampson; A Stormorken; S Tejpar; H J W Thomas; J Wijnen
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

View more
  9 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

2.  Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis.

Authors:  Y A Alderlieste; E A J Rauws; E M H Mathus-Vliegen; P Fockens; E Dekker
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 3.  Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management.

Authors:  Priyanka Kanth; Jade Grimmett; Marjan Champine; Randall Burt; N Jewel Samadder
Journal:  Am J Gastroenterol       Date:  2017-08-08       Impact factor: 10.864

Review 4.  Aspirin in the chemoprevention of colorectal neoplasia: an overview.

Authors:  Andrew T Chan; Nadir Arber; John Burn; Whay Kuang Chia; Peter Elwood; Mark A Hull; Richard F Logan; Peter M Rothwell; Karsten Schrör; John A Baron
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-14

5.  Identification a nonsense mutation of APC gene in Chinese patients with familial adenomatous polyposis.

Authors:  Haishan Li; Lingling Zhang; Quan Jiang; Zhenwang Shi; Hanxing Tong
Journal:  Exp Ther Med       Date:  2017-02-14       Impact factor: 2.447

6.  Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.

Authors:  Rachel A Levy; Vanessa W Hui; Rupa Sood; Stephanie Fish; Arnold J Markowitz; Richard J Wong; José G Guillem
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 7.  Familial colon cancer syndromes: an update of a rapidly evolving field.

Authors:  Swati G Patel; Dennis J Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2012-10

8.  Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.

Authors:  N Jewel Samadder; Deborah W Neklason; Kenneth M Boucher; Kathryn R Byrne; Priyanka Kanth; Wade Samowitz; David Jones; Sean V Tavtigian; Michelle W Done; Therese Berry; Kory Jasperson; Lisa Pappas; Laurel Smith; Danielle Sample; Rian Davis; Matthew K Topham; Patrick Lynch; Elena Strait; Wendy McKinnon; Randall W Burt; Scott K Kuwada
Journal:  JAMA       Date:  2016 Mar 22-29       Impact factor: 56.272

9.  Hereditary colorectal cancer syndromes and the COVID-19 pandemic: results from a survey conducted in patients enrolled in a dedicated registry.

Authors:  Stefano Signoroni; Chiara Maura Ciniselli; Giovanni Apolone; Marco Vitellaro; Guglielmo Niccolò Piozzi; Maria Teresa Ricci; Marta Pastori; Paolo Merola; Marco Bellazzi; Tatiana Smaldone; Giuseppe Rosito; Claudia Borreani; Paolo Verderio
Journal:  Qual Life Res       Date:  2021-08-23       Impact factor: 3.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.